Recent advances in technology have provided an unprecedented opportunity to develop platforms for implementing precision/personalised medicine in cancer. This conference will discuss the challenges that face us in implementing these approaches.

This meeting is of interest to fundamental, translational and clinical cancer researchers alike, as it will cover several aspects of precision treatment of cancer, ranging from tumour heterogeneity and novel metabolic targets to circulating tumour cells and new drug target discovery strategies.

Deadlines:
Abstract submission deadline: 01 January 2015
Registration deadline: 01 February 2015

Contact Person: Kathryn Wass. email:  Kathryn.wass@nottingham.ac.uk